Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
OMIC Singular Genomics
- 21.450
- -0.260-1.20%
Close Dec 3 16:00 ET
53.88MMarket Cap-618P/E (TTM)
21.460High21.010Low7.95KVolume21.010Open21.710Pre Close170.16KTurnover0.50%Turnover RatioLossP/E (Static)2.51MShares23.41052wk High0.44P/B33.95MFloat Cap5.34052wk Low--Dividend TTM1.58MShs Float1001.100Historical High--Div YieldTTM2.07%Amplitude5.340Historical Low21.406Avg Price1Lot Size
About Singular Genomics Company
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.
Company Profile
SymbolOMIC
Company NameSingular Genomics
Listing DateMay 27, 2021
Issue Price22.00
Founded2016
CEOMr. Andrew Spaventa
MarketNASDAQ
Employees256
Fiscal Year Ends12-31
Address3010 Science Park Road
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-333-7830
Company Executives
- Name
- Position
- Salary
- Andrew Spaventa
- Chairman of the Board and Chief Executive Officer
- 1.57M
- Dr. Jyotsna Ghai, PhD
- Chief Operating Officer
- --
- Dr. Eli Glezer, PhD
- Chief Scientific Officer
- 915.28K
- Dalen Meeter
- Chief Financial Officer and Principal Accounting Officer
- 851.48K
- Jorge Velarde
- Chief Business Officer
- --
- Vincent Brancaccio
- Senior Vice President, Human Resources
- --
- Eric Stier
- Senior Vice President, General Counsel and Secretary
- --
- Dr. Michael J. Pellini,M.D.
- Lead Independent Director
- 131.50K
- Dr. Kim P. Kamdar, PhD
- Independent Director
- 103.61K
- Dr. David L. Barker, PhD
- Independent Director
- 113.61K
- Jason Ryan
- Independent Director
- 113.61K
- Dr. Marcia Eisenberg, PhD
- Independent Director
- 87.05K
- Dr. Elaine R. Mardis, PhD
- Independent Director
- 98.61K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.